BG104593A - Carboxyl substituted chroman derivatives useful as a beta 3 adrenoreceptor agonists - Google Patents

Carboxyl substituted chroman derivatives useful as a beta 3 adrenoreceptor agonists

Info

Publication number
BG104593A
BG104593A BG104593A BG10459300A BG104593A BG 104593 A BG104593 A BG 104593A BG 104593 A BG104593 A BG 104593A BG 10459300 A BG10459300 A BG 10459300A BG 104593 A BG104593 A BG 104593A
Authority
BG
Bulgaria
Prior art keywords
beta
derivatives useful
chroman derivatives
carboxyl substituted
adrenoreceptor agonists
Prior art date
Application number
BG104593A
Other languages
Bulgarian (bg)
English (en)
Inventor
Richard CONNEL
Timothy LEASE
Jeremy Baryza
Original Assignee
Bayer Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Corporation filed Critical Bayer Corporation
Publication of BG104593A publication Critical patent/BG104593A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Detergent Compositions (AREA)
  • Pyrrole Compounds (AREA)
BG104593A 1997-12-19 2000-07-11 Carboxyl substituted chroman derivatives useful as a beta 3 adrenoreceptor agonists BG104593A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US99462097A 1997-12-19 1997-12-19
PCT/US1998/026735 WO1999032476A1 (en) 1997-12-19 1998-12-16 Carboxyl substituted chroman derivatives useful as beta 3 adrenoreceptor agonists

Publications (1)

Publication Number Publication Date
BG104593A true BG104593A (en) 2001-09-28

Family

ID=25540853

Family Applications (1)

Application Number Title Priority Date Filing Date
BG104593A BG104593A (en) 1997-12-19 2000-07-11 Carboxyl substituted chroman derivatives useful as a beta 3 adrenoreceptor agonists

Country Status (24)

Country Link
EP (1) EP1040106B1 (hu)
JP (1) JP2001526282A (hu)
KR (1) KR20010033188A (hu)
CN (1) CN1284952A (hu)
AT (1) ATE222901T1 (hu)
AU (1) AU749097B2 (hu)
BG (1) BG104593A (hu)
BR (1) BR9814302A (hu)
CA (1) CA2316971A1 (hu)
DE (1) DE69807523T2 (hu)
DK (1) DK1040106T3 (hu)
ES (1) ES2183434T3 (hu)
HU (1) HUP0004565A3 (hu)
ID (1) ID26524A (hu)
IL (1) IL136689A0 (hu)
NO (1) NO20003083L (hu)
NZ (1) NZ505200A (hu)
PL (1) PL341229A1 (hu)
PT (1) PT1040106E (hu)
RU (1) RU2223269C2 (hu)
SK (1) SK9362000A3 (hu)
TR (1) TR200001927T2 (hu)
UA (1) UA62993C2 (hu)
WO (1) WO1999032476A1 (hu)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR035605A1 (es) * 2000-12-11 2004-06-16 Bayer Corp Derivados de aminometil cromano di-sustituidos, un metodo para su preparacion, composiciones farmaceuticas y el uso de dichos derivados para la manufactura de medicamentos utiles como agonistas beta-3-adreno-receptores
AR035858A1 (es) * 2001-04-23 2004-07-21 Bayer Corp Derivados de cromano 2,6-sustituidos,composiciones farmaceuticas,uso de dichos derivados para la manufactura de medicamentos utiles como agonistas adrenorreceptores beta-3
JPWO2003033468A1 (ja) * 2001-10-17 2005-02-03 株式会社カネカ （Ｓ）−α−ハロメチルピリジンメタノール誘導体の製造方法
MY147767A (en) * 2004-06-16 2013-01-31 Janssen Pharmaceutica Nv Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
CA2597616A1 (en) 2005-02-17 2006-08-24 Wyeth Cycloalkylfused indole, benzothiophene, benzofuran and indene derivatives
US7560575B2 (en) * 2005-12-28 2009-07-14 Acino Pharma Ag Process for preparation of racemic Nebivolol
EP1803716B1 (en) * 2005-12-28 2012-07-25 Acino Pharma AG A process for preparation of racemic nebivolol
ES2534318B1 (es) * 2013-10-18 2016-01-28 Artax Biopharma Inc. Derivados de cromeno sustituidos por alcóxido como inhibidores de la interacción TCR-Nck
ES2534336B1 (es) * 2013-10-18 2016-01-28 Artax Biopharma Inc. Derivados de cromeno como inhibidores de la interacción TCR-Nck

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1337429C (en) * 1983-12-05 1995-10-24 Guy Rosalia Eugene Van Lommen Derivatives of 2,2'-iminobisethanol
GB8801306D0 (en) * 1988-01-21 1988-02-17 Ici Plc Chemical compounds
US5451677A (en) * 1993-02-09 1995-09-19 Merck & Co., Inc. Substituted phenyl sulfonamides as selective β 3 agonists for the treatment of diabetes and obesity
DE69404039T2 (de) * 1993-06-14 1997-10-16 Pfizer Zweite amine als antidiabetische mittel und für die behandlung von fettleibigkeit
GB9405019D0 (en) * 1994-03-15 1994-04-27 Smithkline Beecham Plc Novel compounds
US5561142A (en) * 1994-04-26 1996-10-01 Merck & Co., Inc. Substituted sulfonamides as selective β3 agonists for the treatment of diabetes and obesity
EP0801060A1 (en) * 1996-04-09 1997-10-15 Pfizer Inc. Heterocyclic Beta-3 Adrenergenic Agonists

Also Published As

Publication number Publication date
EP1040106B1 (en) 2002-08-28
NO20003083D0 (no) 2000-06-15
DE69807523T2 (de) 2003-01-09
JP2001526282A (ja) 2001-12-18
HUP0004565A2 (hu) 2001-08-28
AU1830099A (en) 1999-07-12
TR200001927T2 (tr) 2001-06-21
UA62993C2 (en) 2004-01-15
EP1040106A1 (en) 2000-10-04
BR9814302A (pt) 2000-10-10
PT1040106E (pt) 2002-11-29
NZ505200A (en) 2002-09-27
DK1040106T3 (da) 2002-12-02
ATE222901T1 (de) 2002-09-15
ID26524A (id) 2001-01-11
IL136689A0 (en) 2001-06-14
DE69807523D1 (de) 2002-10-02
KR20010033188A (ko) 2001-04-25
HUP0004565A3 (en) 2002-12-28
CA2316971A1 (en) 1999-07-01
ES2183434T3 (es) 2003-03-16
SK9362000A3 (en) 2001-09-11
NO20003083L (no) 2000-08-15
PL341229A1 (en) 2001-03-26
RU2223269C2 (ru) 2004-02-10
CN1284952A (zh) 2001-02-21
WO1999032476A1 (en) 1999-07-01
AU749097B2 (en) 2002-06-20

Similar Documents

Publication Publication Date Title
MY121031A (en) Process for preparing derivatives of the taxoid family
BG104315A (en) Prostaglandine agonists and their application for the treatment of osteal diseases
BG103335A (en) Application of fumaric acid derivatives
GB2209939B (en) The use of 13,14-dihydro-15-keto-prostaglandins as ocular hypotensive agents
AU2962295A (en) Cannabinoid receptor antagonists
EP0786995A4 (hu)
NO940789L (no) Quinolinkarboksylsyrederivater, deres fremstilling og anvendelse
BG102726A (en) Combined therapy for osteoporosis
WO1997030677A3 (en) Pentafluorobenzenesulfonamides and analogs
DE69635026D1 (de) Varianten des menschlichen wachstumshormons
ITFI910071U1 (it) Piastra per osso per la porzione distale dell'omero.
ES2185009T3 (es) Antagonistas de alfa y beta 3'.
BG104593A (en) Carboxyl substituted chroman derivatives useful as a beta 3 adrenoreceptor agonists
WO1998058911A3 (en) Prostaglandin agonists
MX9804588A (es) Uso de composiciones que comprenden blanqueador de halogeno para suavidad mejorada a la piel.
WO2002048134A3 (en) Di-substituted aminomethyl chroman derivative beta-3 adrenoreceptor agonists
ZA977310B (en) Transdermal propentofylline compositions for the treatment of Alzheimer's disease.
HU9602740D0 (en) Halofanthine free base for the treatment of malaria and compositions
ATE402933T1 (de) Neue sulfonamid-substituierte chroman-derivate verwendbar als beta 3 adrenorezeptor agonisten
AU634003B2 (en) 4-benzyl-5-phenyl-2,4-dihydro-3h-1,2,4-triazol-3-ones and their use as anticonvulsants
BG103649A (en) Method for the preparation of eprosartan
BG104427A (en) Use of ketolides for preparing arterial thrombotic complications related to atherosclerosis
BG103650A (en) Method for the preparation of eprosartan
AU2567097A (en) Novel vitamin d analogues
AU8552098A (en) Pyrazoloquinolinone derivatives as gaba alpha 5 receptor inverse agonists